N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stress
AssigneeSentient Lifesciences, Inc.
InventorGlenn A. Goldstein
Life of this patent
Estimating the term…
Abstract
Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
Claims13
A method for treating tissue damage in a human subject exposed to a high-energy impulse blast, comprising administering N-acetylcysteine amide (NAC amide), or a pharmaceutically acceptable salt, ester, or derivative thereof, in a dose effective for treatment of tissue damage due to the exposure to high-energy impulse blasts.
A method for preventing tissue damage in a human subject exposed to a high-energy impulse blast, comprising administering N-acetylcysteine amide (NAC amide), or a pharmaceutically acceptable salt, ester, or derivative thereof, in a dose effective for preventing tissue damage due to exposure to high-energy impulse blasts.
Dependencies are inferred from the claim text.